Avijit Lahiri

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Avijit Lahiri is a researcher in cardiology[1][2] in the UK.[3]

Career[edit]

He graduated from the Calcutta National Medical College, then affiliated with the University of Calcutta in India. He completed his internship and training at the Northwick Park Hospital, in London. He was a consultant cardiologist and director of cardiac research Institute of Medical Research in Northwick Park Hospital and St. Marks, Imperial College London for over 20 years.

Lahiri is the Director of the Cardiac Imaging and Research Department in Wellington Hospital, London.[4][5][6][7]

Lahiri's research interests are mainly in diagnostic imaging[8][9] and therapeutics in cardiovascular medicine. He was previously Director of Cardiovascular Research at Northwick Park Hospital, where he performed clinical therapeutic trials, and developed cardiac imaging protocols and techniques.[10]

Research and trials[edit]

He has published over 270 peer-reviewed scientific publications[11][12][13][14] [15] [16] [17] 16 book chapters and has presented over 290 invited lectures.[18]

He has contributed[19] to a number of clinical trials, including the first trials of Carvedilol, in heart failure and acute myocardial infarction; the first clinical trial of 7E3 (and its chimeric form), in patients with coronary artery disease; the first clinical trial of Ranolazine in stable angina. He also developed TC-99m tetrofosmin (Myoview) for myocardial perfusion imaging in man in conjunction with Amersham International (now GE).[20]

Awards and recognition[edit]

References[edit]

  1. ^ "Enhanced detection of reversible perfusion defects by Tc-99m sestamibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease". Content.onlinejacc.org. Retrieved 10 December 2014. 
  2. ^ [1][dead link]
  3. ^ "Advisory Team". Archived from the original on May 17, 2011. Retrieved February 25, 2010. 
  4. ^ [2] Archived July 17, 2011, at the Wayback Machine.
  5. ^ "Eminent British Cardiologist, Pioneer in Nuclear Cardiology, Dr. Avijit Lahiri, Wellington Hospital, London, UK, Europe". Britishcardiacresearch.org. Retrieved 10 December 2014. 
  6. ^ [3][dead link]
  7. ^ "BMJ Careers - Nuclear cardiology". Mahealthcareevents.co.uk. Retrieved 10 December 2014. 
  8. ^ "Heart Scan News". Archived from the original on January 26, 2010. Retrieved February 25, 2010. 
  9. ^ "Latest News - AandD Medical UK". Aandd-eu.net. Retrieved 10 December 2014. 
  10. ^ "Setting up a myocardial perfusion scintigraphy service: Clin... : Nuclear Medicine Communications". LWW. Retrieved 10 December 2014. 
  11. ^ [4][dead link]
  12. ^ "Search Results". Download.journals.elsevierhealth.com. Retrieved 10 December 2014. 
  13. ^ "October 2003 - Volume 24 - Issue 10 : Nuclear Medicine Communications". Journals.lww.com. Retrieved 10 December 2014. 
  14. ^ "Role of myocardial perfusion imaging for risk stratification in suspected or known coronary artery disease". Heart.bmj.com. Retrieved 10 December 2014. 
  15. ^ "October 2003 - Volume 24 - Issue 10 : Nuclear Medicine Communications". Nuclearmedicinecomm.com. Retrieved 10 December 2014. 
  16. ^ Sumit Basu. "Beneficial Effects of Intravenous and Oral Carvedilol Treatment in Acute Myocardial Infarction". Circ.ahajournals.org. Retrieved 10 December 2014. 
  17. ^ "Advanced Ultrasound". Diagnosticimaging.com. Retrieved 10 December 2014. 
  18. ^ "Short CV" (PDF). Archived from the original (PDF) on March 3, 2012. Retrieved February 25, 2010. 
  19. ^ "The role of cardiovascular imaging techniques in the assessm... : Nuclear Medicine Communications". LWW. Retrieved 10 December 2014. 
  20. ^ [5][dead link]
  21. ^ "Obituary: Dr. Edward Bernard Raftery died 16 July 1995". Cardiovascular Drugs and Therapy. 10: 193. doi:10.1007/BF00823599. Retrieved 10 December 2014. 
  22. ^ "Free Prescriptions, Patient Assistance Programs, Free Medicine". Themedicineprogram.com. Retrieved 10 December 2014. 
  23. ^ "What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination? - European Heart Journal". Eurheartj.oxfordjournals.org. Retrieved 10 December 2014.